Moleculin Biotech (0K2H) Ownership - Who Owns Moleculin Biotech?
Moleculin Biotech (0K2H) Ownership Overview
- 6.30% Insiders
- 0.14% Mutual Funds
- 0.20% ETFs
- 93.35% Public Companies and Individual Investors
The ownership structure of Moleculin Biotech (GB:0K2H) stock is a mix of institutional, retail, and individual investors. Approximately 0.34% of the company’s stock is owned by Institutional Investors, 6.30% is owned by Insiders, and 93.35% is owned by Public Companies and Individual Investors.
The ownership structure of Moleculin Biotech (GB:0K2H) stock is a mix of institutional, retail, and individual investors. Approximately 0.34% of the company’s stock is owned by Institutional Investors, 6.30% is owned by Insiders, and 93.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Walter V Klemp | 723,181 | Insider | 68.87% | 3,844,430 |
| Jonathan P. Foster | 405,188 | Insider | 38.59% | 2,153,979 |
| Donald H Picker | 174,086 | Insider | 16.58% | 925,441 |
| Vanguard | 42,215 | Institution | 4.02% | 224,415 |
| George Robert E. | 14,660 | Insider | 1.40% | 77,933 |
| BlackRock, Inc. | 491 | Institution | 0.05% | 2,610 |
FAQ
Who Owns Moleculin Biotech (GB:0K2H)?
According to the latest TipRanks data, approximately 0.34% of the company's stock is held by institutional investors, 6.30% is held by insiders, and 93.35% is held by public companies and individual investors.
What percentage of Moleculin Biotech (GB:0K2H) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.34% of Moleculin Biotech (GB:0K2H) stock is held by institutional investors: 0.14% by mutual funds and 0.20% by ETFs.
What percentage of Moleculin Biotech (GB:0K2H) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.35% of Moleculin Biotech (GB:0K2H) stock is held by public companies and individual investors.
Who owns the most shares of Moleculin Biotech (GB:0K2H)?
WALTER V KLEMP owns the most shares of Moleculin Biotech (GB:0K2H).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
